News
White blood cell counts higher among CRAO patients
3+ hour, 14+ min ago (529+ words) Findings from a retrospective observational study published in BMC Ophthalmology found that central retinal artery occlusion (CRAO) carries higher peripheral leukocyte and lymphocyte levels than branch retinal artery occlusion (BRAO). The authors argued that the two subtypes are immunologically distinct…...
Vermont passes bill authorizing optometric laser procedures
12+ hour, 4+ min ago (407+ words) The optometric community secured its latest legislative win last week after Vermont Gov. Phil Scott signed a new law authorizing doctors of optometry to perform ophthalmic lasers. The state is now the 17th to permit such scope of practice advancements (but…...
ZEISS and Envision Health Technologies partner on VR functional testing for glaucoma
1+ day, 5+ hour ago (390+ words) ZEISS Medical Technology and Envision Health Technologies are teaming up to advance glaucoma management through virtual reality (VR)-based visual function testing. Launched in 2022 and based in New York City, New York, the privately-held digital eye health company was founded…...
The Myopia Collective adds Student Change Agent advocates to nationwide initiative
6+ day, 12+ hour ago (414+ words) The Myopia Collective (TMC) selected a new cohort of optometrist (OD) Change Agents this week as part of the national initiative's continued expansion in targeting myopia management care among pediatric patients. And for the first time: The program also welcomed…...
Domp" kicks off patient dosing in phase 3 PCED trial on cenegermin-bkbj
1+ week, 2+ day ago (420+ words) Domp" recently announced that the first patient has been dosed in the United States in the phase 3 ORUNEA study of cenegermin-bkbj ophthalmic solution for the treatment of persistent corneal epithelial defect (PCED). Operating its international business out of Italy'with U. S. headquarters…...
Carrot expands VR diagnostics with real-time analytics dashboard
1+ week, 6+ day ago (212+ words) Carrot (formerly Virtual Field) recently launched a new addition to its virtual reality (VR) visual diagnostic system: a real-time analytics dashboard for eyecare practices. You bet. In fact, we can do you one better and direct you toward our coverage…...
Atropine taper leads to less pediatric myopia progression
2+ week, 6+ hour ago (587+ words) Stopping atropine treatment for myopia control has long been a weak spot in otherwise well-established management strategies. And while low-dose atropine is widely used to slow axial elongation, its effects don't carry over once treatment ends. Many clinicians have observed…...
Harrow relaunches VERKAZIA for vernal keratoconjunctivitis
2+ week, 13+ hour ago (298+ words) What it is: A prescription-based calcineurin inhibitor immunosuppressant formulated as an ophthalmic emulsion intended for topical administration. Its indication: For the treatment of VKC in children and adults. See its prescribing information (PI) for: Its claim to fame: VERKAZIA is…...
FDA clears Heidelberg's new SPECTRALIS software release
2+ week, 1+ day ago (367+ words) Heidelberg Engineering Gmb has received FDA clearance for the latest release of its SPECTRALIS software, designed for multimodal retinal imaging. This would be FDA 510(k) clearance, as this pathway is utilized for modifications to existing devices (such as the SPECTRALIS). What…...
Alkeus begins dosing in global phase 3 Stargardt trial on oral gildeuretinol
2+ week, 1+ day ago (521+ words) Alkeus Pharmaceuticals, Inc. recently announced that the first patient was dosed in the pivotal phase 3 NORTHSTAR study of oral gildeuretinol (ALK-001) for the treatment of Stargardt disease (SD). What it is: Oral gildeuretinol acetate is a new molecular entity designed…...